Markedly effective local control of hepatocellular carcinoma with a poor prognosis by combined multimodal therapy with sorafenib as a neoadjuvant approach.

Source:http://linkedlifedata.com/resource/pubmed/id/20207091

Download in:

View as

General Info

PMID
20207091